Clinical Trials

Primary Investigator: Elias S. Siraj, MD

Summary: The purpose of this study is to evaluate the effects of dapagliflozin as compared with placebo on heart failure disease-specific biomarkers, symptoms, health status and quality of life in patients with chronic heart failure with preserved systolic function.

Point of contact: Henri Parson, PhD, or Norine Kuhn

Start date: 9/7/2017

You may be eligible to participate in this study if you:

• Have been diagnosed with chronic heart failure
• Are at least 18 years old

Primary Investigator: Aaron Vinik, MD, PhD, FCP, MACP, FACE

Summary: The primary objective of this study is to determine if oral Topiramate slows progression of Cryptogenic Sensory Peripheral Neuropathy (CSPN) in subjects with Metabolic Syndrome and pre-diabetes.

Point of contact: Carolina Casellini, MD, and Henri Parson, PhD

Start date: 03/27/2018

You may be eligible to participate in this study if you are:

• Are at least 18 years old
• Have signs of metabolic disease including abdominal obesity, pre-diabetes, high blood pressure and abnormal cholesterol/lipids
• Have numbness and tingling on the feet

Primary Investigator: Elias S. Siraj, MD

Summary: The purpose of this study is to determine if semaglutide may reduce the risk of cardiovascular events (e.g, stroke, heart attack) in patients that are overweight or obese and have a history of cardiovascular disease.

Point of contact: Henri Parson, PhD, or Norine Kuhn

Start date: 12/1/2018

You may be eligible to participate in this study if you are:

• Diagnosed with cardiovascular disease
• Overweight or obese
• At least 18 years old

Primary Investigator: Aaron Vinik, MD, PhD, FCP, MACP, FACE

Summary: This study is designed to better understand factors that impact or lead to the perception of fatigue in subjects diagnosed with either type 1 (T1DM) or type 2 diabetes mellitus (T2DM) who are who are between 18-80.

Point of contact: Carolina Casellini, MD and Henri Parson, PhD

Start date: 01/31/2017

You may be eligible to participate in this study if you are:

• Are at least 18 years old
• Have type 1 or type 2 diabetes